Ningbo MedicalSystem Return On Equity vs. Cash Flow From Operations

300439 Stock   11.43  0.05  0.44%   
Taking into consideration Ningbo MedicalSystem's profitability measurements, Ningbo MedicalSystem Biotechnology may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess Ningbo MedicalSystem's ability to earn profits and add value for shareholders.
For Ningbo MedicalSystem profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Ningbo MedicalSystem to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Ningbo MedicalSystem Biotechnology utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Ningbo MedicalSystem's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Ningbo MedicalSystem Biotechnology over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Ningbo MedicalSystem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ningbo MedicalSystem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ningbo MedicalSystem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Ningbo MedicalSystem Cash Flow From Operations vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Ningbo MedicalSystem's current stock value. Our valuation model uses many indicators to compare Ningbo MedicalSystem value to that of its competitors to determine the firm's financial worth.
Ningbo MedicalSystem Biotechnology is number one stock in return on equity category among its peers. It also is number one stock in cash flow from operations category among its peers making about  6,790,269,561  of Cash Flow From Operations per Return On Equity. Comparative valuation analysis is a catch-all model that can be used if you cannot value Ningbo MedicalSystem by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Ningbo MedicalSystem's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Ningbo Cash Flow From Operations vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Ningbo MedicalSystem

Return On Equity

 = 

Net Income

Total Equity

 = 
0.0933
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.

Ningbo MedicalSystem

Operating Cash Flow

 = 

EBITDA

-

Taxes

 = 
633.53 M
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.

Ningbo Cash Flow From Operations Comparison

Ningbo MedicalSystem is currently under evaluation in cash flow from operations category among its peers.

Ningbo MedicalSystem Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Ningbo MedicalSystem, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Ningbo MedicalSystem will eventually generate negative long term returns. The profitability progress is the general direction of Ningbo MedicalSystem's change in net profit over the period of time. It can combine multiple indicators of Ningbo MedicalSystem, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income253 M283.2 M
Income Before Tax295.7 M184.2 M
Net Income Applicable To Common Shares178.7 M91.6 M
Net Income256.6 M139 M
Income Tax Expense20.8 M19.8 M
Net Income From Continuing Ops259.5 M145 M
Total Other Income Expense Net544.2 K571.4 K
Net Interest Income2.4 M2.5 M
Interest Income13.3 M13.9 M
Change To Netincome117.4 M196.4 M

Ningbo Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Ningbo MedicalSystem. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Ningbo MedicalSystem position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Ningbo MedicalSystem's important profitability drivers and their relationship over time.

Use Ningbo MedicalSystem in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ningbo MedicalSystem position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ningbo MedicalSystem will appreciate offsetting losses from the drop in the long position's value.

Ningbo MedicalSystem Pair Trading

Ningbo MedicalSystem Biotechnology Pair Trading Analysis

The ability to find closely correlated positions to Ningbo MedicalSystem could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ningbo MedicalSystem when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ningbo MedicalSystem - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ningbo MedicalSystem Biotechnology to buy it.
The correlation of Ningbo MedicalSystem is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ningbo MedicalSystem moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ningbo MedicalSystem moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ningbo MedicalSystem can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Ningbo MedicalSystem position

In addition to having Ningbo MedicalSystem in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Aluminum Thematic Idea Now

Aluminum
Aluminum Theme
Companies involved in production of aluminum. The Aluminum theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aluminum Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Ningbo Stock

To fully project Ningbo MedicalSystem's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Ningbo MedicalSystem at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Ningbo MedicalSystem's income statement, its balance sheet, and the statement of cash flows.
Potential Ningbo MedicalSystem investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Ningbo MedicalSystem investors may work on each financial statement separately, they are all related. The changes in Ningbo MedicalSystem's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ningbo MedicalSystem's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.